Intuitive Surgical (ISRG) Price Target Increased to $475.00 by Analysts at Barclays

Intuitive Surgical (NASDAQ:ISRG) had its target price upped by analysts at Barclays to $475.00 in a note issued to investors on Friday, Marketbeat Ratings reports. The firm presently has an “overweight” rating on the medical equipment provider’s stock. Barclays’ price objective would indicate a potential upside of 7.90% from the company’s current price. The analysts noted that the move was a valuation call.

Other equities analysts have also recently issued reports about the stock. BidaskClub raised shares of Intuitive Surgical from a “buy” rating to a “strong-buy” rating in a research note on Thursday, January 11th. Wells Fargo & Co reissued a “buy” rating on shares of Intuitive Surgical in a research note on Monday, October 16th. Stifel Nicolaus reissued a “buy” rating and issued a $480.00 price objective (up from $400.00) on shares of Intuitive Surgical in a research note on Thursday. Piper Jaffray Companies reissued a “hold” rating on shares of Intuitive Surgical in a research note on Friday. Finally, Leerink Swann reissued an “outperform” rating and issued a $475.00 price objective (up from $390.00) on shares of Intuitive Surgical in a research note on Thursday, January 18th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $409.40.

Intuitive Surgical (ISRG) opened at $440.24 on Friday. The stock has a market cap of $48,280.00, a price-to-earnings ratio of 77.51, a price-to-earnings-growth ratio of 5.37 and a beta of 0.47. Intuitive Surgical has a 12 month low of $227.38 and a 12 month high of $452.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, January 25th. The medical equipment provider reported $2.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.27 by $0.27. The company had revenue of $892.40 million for the quarter, compared to analysts’ expectations of $866.54 million. Intuitive Surgical had a net margin of 21.09% and a return on equity of 20.14%. Intuitive Surgical’s revenue was up 17.9% compared to the same quarter last year. During the same period in the previous year, the company posted $2.03 EPS. research analysts anticipate that Intuitive Surgical will post 7.85 EPS for the current year.

In other news, COO Salvatore Brogna sold 6,082 shares of the company’s stock in a transaction on Friday, December 1st. The shares were sold at an average price of $397.61, for a total transaction of $2,418,264.02. Following the transaction, the chief operating officer now directly owns 3,096 shares of the company’s stock, valued at approximately $1,231,000.56. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Mark J. Rubash sold 6,000 shares of the company’s stock in a transaction on Friday, December 1st. The stock was sold at an average price of $395.95, for a total transaction of $2,375,700.00. Following the transaction, the director now directly owns 5,453 shares in the company, valued at $2,159,115.35. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 28,621 shares of company stock worth $11,216,568. Corporate insiders own 2.20% of the company’s stock.

Large investors have recently bought and sold shares of the company. CWM LLC grew its stake in shares of Intuitive Surgical by 200.0% during the 4th quarter. CWM LLC now owns 285 shares of the medical equipment provider’s stock worth $104,000 after purchasing an additional 190 shares during the period. American National Bank boosted its position in shares of Intuitive Surgical by 200.0% in the 4th quarter. American National Bank now owns 300 shares of the medical equipment provider’s stock worth $109,000 after buying an additional 200 shares in the last quarter. ETF Managers Group LLC purchased a new stake in shares of Intuitive Surgical in the 2nd quarter worth about $110,000. Trust Department MB Financial Bank N A boosted its position in shares of Intuitive Surgical by 200.0% in the 4th quarter. Trust Department MB Financial Bank N A now owns 345 shares of the medical equipment provider’s stock worth $126,000 after buying an additional 230 shares in the last quarter. Finally, Cerebellum GP LLC purchased a new stake in shares of Intuitive Surgical in the 4th quarter worth about $127,000. 33.11% of the stock is currently owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: “Intuitive Surgical (ISRG) Price Target Increased to $475.00 by Analysts at Barclays” was first reported by American Banking News and is owned by of American Banking News. If you are viewing this report on another website, it was copied illegally and republished in violation of United States and international copyright law. The correct version of this report can be viewed at https://www.americanbankingnews.com/2018/01/27/barclays-raises-intuitive-surgical-isrg-price-target-to-475-00.html.

About Intuitive Surgical

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply